New Publication about the on-field evaluation of the FRENDTM COVID-19 Ag assay as a frontline test for SARS-CoV-2 diagnostic
We are happy to share below a new publication which shows the excellent performance of the FRENDTMCOVID-19 Ag assay (NanoEntek, South Korea) as a frontline test for SARS-CoV-2 identification in comparison to the available molecular techniques and to the STANDARD F COVID-19 Ag FIA test, a rapid fluorescent immunoassay test currently used in clinical practice.
The FRENDTM COVID-19 Ag assay test showed high sensitivity and specificity in nasopharyngeal swabs. In the conclusion it is descibed as an assay which has the potential to become an important tool for an ultra-rapid identification of SARS-CoV-2 infection, particularly in situations with limited access to molecular diagnostics.
On-field evaluation of the FRENDTM COVID-19 Ag assay as a frontline test for SARS-CoV-2 diagnostic